Activity of trovafloxacin against blood isolates of Streptococcus pneumoniae in Sweden

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 15, Issue 8, 1996, Pages 671-675

  Olsson Liljequist, B ^a   Huffman, B M ^b   Hedlund, J ^a  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; OFLOXACIN; PENICILLIN G; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM; TROVAFLOXACIN;

ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; SWEDEN;

EID: 0029792279     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01691157     Document Type: Article

References (19)

1. Eliopoulos GM, Klimm K, Eliopoulos CT, Ferraro MJ, Moellering RC Jr: In vitro activity of CP-99,219, a new fluoroquinolone against clinical isolates of gram-positive bacteria. Antimicrobial Agents and Chemotherapy 1993, 37:366-370.
2. Ito A, Hirai K, Inoue M, Koga H, Suzue S, Irikura T, Misuhashi S: In vitro antibacterial activity of AM-715, anew nalidixic acid analog. Antimicrobial Agents and Chemotherapy 1980, 17: 103-108.
3. Chin NX, Neu HC: Ciprofloxacin, a quinolone carboxylic acid compound against aerobic and anaerobic bacteria. Antimicrobial Agents and Chemotherapy 1984, 25: 329-326.
4. Sato K, Matsuura Y, Inoue M, Une T, Osada Y, Ogawa S, Mitsuhashi S: In vitro and in vivo activity of DL-8280, a new oxazine derivative. Antimicrobial Agents and Chemotherapy 1982, 22: 548-553.
5. Fuchs PC, Barry AL, Jones RN, Thornsberry C: Evaluation of in vitro antibacterial activity of enoxacin: comparison with other orally absorbed antimicrobial agents, proposed disk diffusion test interpretative criteria, and quality control limits. Diagnostic Microbiology and Infectious Disease 1985, 3: 213-221.
6. Hooper DC, Wolfson JS: Fluoroquinolone antimicrobial agents. New England Journal of Medicine 1991, 324: 384-395.
7. Wolfson JS, Hooper DC: Fluoroquinolone antimicrobial agents. Clinical Microbiology Reviews 1989, 2: 378-424.
8. Gooding BB, Jones RN: In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone. Antimicrobial Agents and Chemotherapy 1993, 37: 349-353.
9. Neu HC, Chin N-X: In vitro activity of the new fluoroquinolone CP-99,219. Antimicrobial Agents and Chemotherapy 1994, 38: 2626-2632.
10. Gootz TD, Brighty KE, Anderson MR, Haskell SL, Sutcliffe JA, Castaldi MJ, Castaldi MJ, McGuirk PR: In vitro activity of CP-99,219, a novel 7-(3azabicyclo[3.1.0]hexyl)naphthyridone antimicrobial. Diagnostic Microbiology and Infectious Disease 1994,19: 235-243.
11. Mufson MA: Streptococcus pneumoniae. In: Mandell GL, Douglas R, Bennett JE (ed): Principles and practice of infectious diseases. Churchill Livingstone, Edinburgh, 1990. p. 1539-1550.
12. Appelbaum PC: Antimicrobial resistance in Streptococcus pneumonias', an overview. Clinical Infectious Diseases 1992, 15: 77-83.
13. Baquero F, Martinez-Beltran J, Loza E: A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. Journal of Antimicrobial Chemotherapy 1991. 28, Supplement C: 31-38.
14. Klugman KP: Pneumococcal resistance to antibiotics. Clinical Microbiology Reviews 1990, 3: 171-196.
15. Ericsson HM, Sherris JC: Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathologica et Microbiologica Scandinavica (B) 1971, Supplement 217: 1-90.
16. Forsgren A, Walder M: Antimicrobial susceptibility of bacteria isolated in South Sweden including a 13-year follow-up study of some respiratory tract pathogens. Acta Pathologica, Microbiologica, et Immunologica Scandinavica 1994, 102: 227-235.
17. Breiman RF, Butler JC, Tenover FC, Elliot JA, Facklam RR: Emergence of drug resistant pneumococcal infections in the United States. Journal of the American Medical Association 1994, 271: 1831-1835.
18. Munoz R, Coffey TJ, Daniels M, Dowson CG, Laible G, Casal J, Hakenbeck R, Jacobs M, Musser JM, Spratt BG: Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. Journal of Infectious Diseases 1991, 164: 302-306.
19. Linares J, Pallares A, Alonso T, Perez JL, Ayats J, Guidol F, Viladrich PF, Martin R: Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clinical Infectious Diseases 1992, 15: 99-105.